Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMS

NEW ORLEANS – The recently published results of the INFORMS multicenter, double-blind, placebo-controlled parallel-group study (NCT00731692) that compared the efficacy of fingolimod in slowing...
Source: Clinical Neurology News - Category: Neurology Source Type: news
More News: Brain | Gilenya | Neurology | Study